BioPharma Resources

Free tool

Expedited programs

FDA has four main ways to speed a drug to patients: breakthrough therapy designation, accelerated approval on a surrogate endpoint, priority review, and orphan designation for rare diseases. This page counts approvals, original and supplemental, that used each one. Fast track is not counted because FDA publishes no list of it.

Last checked: Nov 18, 2026Source: FDA CDER lists and Drugs@FDAMethods & limitations

Approvals by program and year

An approval can count under several programs. Since 2012, when breakthrough therapy designation began.

  • Breakthrough therapy
  • Accelerated approval
  • Priority review
  • Orphan
View as table
YearBreakthrough therapyAccelerated approvalPriority reviewOrphan
2012084829
2013344730
20141497152
20152097658
20162177559
20173010119100
2018389147130
20192510132100
20203120139126
2021301713997
202226911794
20231712111118
20243011114136
20253513119164
2026155106104

Breakthrough therapy

On CDER's list of approvals for drugs with Breakthrough Therapy designation. Source: CDER Breakthrough Therapy Designation Approvals list.

List them

Most approvals since 2012

Accelerated approval

On CDER's list of accelerated approvals based on a surrogate endpoint. Source: CDER accelerated approvals based on a surrogate endpoint.

List them

Most approvals since 2012

Priority review

FDA gave the original application priority review: a 6-month goal instead of 10. Source: Drugs@FDA review priority.

List them

Most approvals since 2012

Orphan

Drugs@FDA marks at least one approval of this application as for an orphan-designated use (a rare disease). Source: Drugs@FDA orphan marking.

List them

Most approvals since 2012

Looking ahead? The PDUFA calendar lists announced FDA action dates.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.